Shepherd, Finkelman, Miller & Shah, LLP
Shepherd, Finkelman, Miller & Shah, LLP
866-540-5505 877-891-9880

Dedicated Client Advocacy

May 2017 Archives

Proposed Class Demands Docs in Namenda Antitrust Suit

The high costs of health care is a major issue in the U.S., which was highlighted in 2015 when Turing Pharmaceuticals notoriously increased the price of the drug that is used as the standard of care for treating a life-threatening parasitic infection from $13 to $750 overnight. When drug companies monopolize a drug through patents, it makes it extremely hard to maintain affordable prices, which becomes particularly unjust when dealing with people's health. Luckily, antitrust laws can help remedy this effect of monopolized drugs.

Feds intervene in health care fraud whistleblower lawsuits

What do you do if you are a billing employee for a health care entity in Connecticut or elsewhere -- a doctor's office, say, or a hospital, clinic, pharmacy, medical device maker, pharmaceutical manufacturer or other participant -- and you note an incongruity between a product or services code and what a patient or other party actually received?

Product liability focus: SCOTUS lets lower-court's GM ruling stand

General Motors' executives and shareholders have been decidedly unhappy for over a week now, in the wake of a U.S. Supreme Court action that essentially crushed hopes that the behemoth automaker might escape future liability that could potentially cost the company a flatly astronomical amount of money.